Acadia Pharmaceuticals INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSan Diego, CA
US patents92
SAM.gov UEID79ND8GZR3E6
CAGE code5LB84
Incorporated inDE
LEI529900O3044NO0PEA039
Patents
92 US patents granted 1999–2024, 16 of them in the five years to SEP 2025.
Pharmaceuticals 67Organic fine chemistry 18Measurement 7
- Compounds, salts thereof and methods for treatment of diseasesUS 12,139,477 · granted NOV 12, 2024
- Agitation process for preparing a carbetocin drug productUS 11,844,764 · granted DEC 19, 2023
- Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form cUS 11,840,515 · granted DEC 12, 2023
- Crystalline forms of trofinetideUS 11,827,600 · granted NOV 28, 2023
- Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosisUS 11,464,768 · granted OCT 11, 2022
Newest 5 shown · Granted to ACADIA Pharmaceuticals Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Acadia Pharmaceuticals INC | San Diego | CA | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.
